Summit Therapeutics stock falls as MACD Death Cross and Bollinger Bands narrow.

According to the 15-minute chart of Summit Therapeutics, there have been two recent indicators that suggest a potential downward trend in the stock price. Firstly, the MACD (Moving Average Convergence Divergence) has triggered a "death cross," which is a bearish signal indicating that the short-term moving average is crossing below the long-term moving average. Secondly, the Bollinger Bands have narrowed, which suggests that the magnitude of stock price fluctuations is decreasing. This suggests that the stock price has the potential to continue falling, and investors should be cautious about their investments.